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Anti-bacterialAbstract Bioactive flavonoids derived from Asplenium nidus (fern) possess potent tumoricidal,
anti-bacterial, anti-oxidant activities that are responsible for their chemo-preventive potential
against multidrug-resistant (MDR) pathogens, Proteus mirabilis, Proteus vulgaris and Pseudomonas
aeruginosa. Fractionation and recognition of the flavonoids were attained through gas chromatog-
raphy and mass spectrometry (GC/MS). Twelve known and three unknown compounds were
revealed by fractions 1 & 3, representing 13.12% and 2.61% out of the total composition
(15.12%). Gliricidin7-O-hexoside was found 3.83% followed by quercetin-7-O-rutinoside (3.09%)
keampferol-3-O-rutinoside (0.19%) and myricetin-3-O-rhamnoside (1.10%). The anti-bacterial
and anti-oxidant activities of present fractions along with pure bioactive constituents were tested
against three MDR pathogens through microbroth dilution: MIC50 ranges for amoxicillin,
gliricidin7-O-hexoside and quercetin 7-O-rutinoside were 0.0003–0.06 lg/mL, 0.004–0.06 lg/mL
and 0.005–6.0 lg/mL, respectively. Gliricidin-7-O-hexoside and quercetin-7-O-rutinoside’s inhibi-
tory activities were comparable to standard antibiotic, amoxicillin (p> 0.05). Herein we report
for the first time a number of flavonoids that may act as the source of therapeutically useful com-
pounds against MDR pathogens. In addition, the most extracted flavonoids (gliricidin-7-O-
hexoside (78.1%) and quercetin-7-O-rutinoside (69.2%) showed a significant in vitro antioxidant
activity i.e. DPPH radical scavenging activity. Both fractions of A. nidus showed obvious cytotoxic
effects on human hepatoma HepG2 and human carcinoma HeLa cells. Moreover, the anti-cancer
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186 R. Jarial et al.activity generally enhanced with ameliorating antioxidant and antibacterial potential of fern’s fla-
vonoids. These findings illustrate the potential of this fern as a probable source of bioactive con-
stituents and provide a scientific basis for its folklore or ethno-medicinal uses for infectious
diseases and cancers.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ferns are generally used in traditional medicine for the cure of
many deadly diseases like skin problems, wounds, cough and
reproductive problems as well as to make insect repellent
(Nath et al., 2016; Bahadori et al., 2015). A wide range of med-
icine ferns like Adiantum capillus-veneris, Cheilanthes albo-
marginata including, A. nidus exist in Asia (Chang et al.,
2005). A. nidus Linn is a member of Aspleniaceae which is com-
monly known to the locals as the ‘langsuyar’ or the bird’s nest
fern (Fig. 1). It has a rosette-shaped basket consisting of long
fronds (Ellwood et al., 2002). It has been reported that A. nidus
not only is extensively used to treat elephantiasis and to,
reduce fever but also showed remarkable antiviral activity
toward Herpes simplex virus Type-1(HSV-1) (Hammami
et al., 2016; Campos et al., 2011). A. nidus has been used locally
in folk medicine for asthma, sores, weakness and halitosis
(Duke, 2011).
In the plant kingdom, flavonoids are commonly found,
with approximately 10,000 known structures (Babii et al.,
2016; Wang et al., 2016; Bohin et al., 2012) and have attracted
much enthusiasm for possessing potential bioactivities, just as
neuro-protective (Wang et al., 2016; Hwang et al., 2012),
tumoricidal, (Kurzawa-Zegota et al., 2012; Wei et al., 2012)
and anti-glycative activities (Verzelloni et al., 2011). It is plau-
sible because of their anti-oxidant properties (Wang et al.,
2016; Xie et al., 2012).
The major identified constituents in A. nidus plants are phe-
nols and flavonoids (Hammami et al., 2016) yet little informa-
tion about flavonoids in A. nidus (Iwashina et al., 2000) is
available. Likewise, little research has been performed on the
phytochemical components of ferns including A. nidus andplenium nidus.their bioactivities. The aim of our study was to assess the
phytochemical investigations were carried out yielding in the
isolation of new flavonol derivatives with antioxidant proper-
ties from A. nidus. Flavonoid derivatives of A. nidus were
identified by gas chromatography and mass spectrometry
(GC/MS). In addition the anti-oxidant, anti-cancer and anti-
bacterial properties were investigated from the profiles of
isolated flavonoids from A. nidus against MDR pathogens.
To the best of our knowledge, this compound is being reported
in A.nidus for the first time. It is worth mentioning that
because of the excellent anti-oxidant, anti-bacterial and anti-
cancer activities.2. Experimental
2.1. Chemicals and reagents
All chemicals used were of the highest purity (P99.0%) and
were purchased from Sigma Aldrich and Merck Malaysia, as
follows: NaCl, HCl, FeCl2, ethanol, methanol, acetone,
H2SO4, ferric chloride, KCl, Na2HPO4, chloroform, conc.
H2SO4, acetic anhydride, KH2PO4, NaNO2, AlCl3, NaOH,
H2O2, Na2CO3, ferrozine, FeSO4 and glacial acetic acid. Bac-
terial strains were bought by University Malaya (UM), Malay-
sia. The GC and GC/MS techniques were used on Hewlett-
Packard (HP) 5973 with HP-6890 gas chromatograph having
HP5 column of 30 m  0.25 mm i.d with 0.25 lm of film thick-
ness. Strains were cultivated in nutrient broth. The human car-
cinoma HeLa cells were provided by the University Malaya
(UM) research laboratory. The Dulbecco’s Modified Eagle’s
Medium (DMEM; Sigma Chemical Company, MO, Saint
Louis, USA) with 10% heat-inactivated fetal bovine serum
in a humidified atmosphere with 5% CO2 at 37 C were used
for cell maintenance.2.2. Preparation of plant extract
The fresh fern/plant material (whole plant) was washed under
running tap water, air-dried and homogenized into fine pow-
der. The powered preparations were stored in air-tight glass
vials. For preparing tissue extracts, 1.0 g of the homogenized
powder was placed in 10 ml of methanol in a conical flask, cov-
ered with cotton cap and kept on a rotary shaker at 200 rpm
for 48 h. The extract was filtered through Whatmann filter
paper No.1, the resultant filtrate of which was centrifuged at
10,000 rpm at 4 C for 15 min. The supernatant was collected
and completely evaporated at room temperature. The left-
over methanolic fern extract (MFE) residue was dissolved in
0.05 M Phosphate buffered saline (PBS), pH 7.2 to reach a
final concentration and was sterilized by filtration (0.22 lm
Millipore filter). The filter-sterilized preparation of MFEs thus
Anticancer, antioxidant and antibacterial activities of flavonoids from Asplenium nidus 187obtained was stored in a freezer at 70 C in air-tight vials for
further studies.
2.3. Flavonoid assays
The flavonoid assays were performed according to the
reported procedure (Belmekki and Bendimerad, 2012). The
determination of flavonoids was performed according to the
colorimetric assay. Diluted ammonia (5 ml) solution was
mixed with plant extract, followed by slow addition of concen-
trated H2SO4. A yellow coloration in the extract which dimin-
ished on standing indicated the presence of flavonoids.
2.4. Quantitative assay for flavonoids
The flavonoid assay was done according to the reported proce-
dure. The aluminum chloride (AlCl3) colorimetric assay was
used to determine the total flavonoid content in MFE
(Marinova et al., 2005). 0.5 ml of sample (2000 lg/ml) was
added to 2.8 ml of distilled water, 0.1 ml of 1 M potassium
acetate, and 0.1 ml of 10% aluminum chloride. The content
was mixed using a vortex and incubated at 37 C for half an
hour. The absorbance was measured at 510 nm with a micro
plate reader (Molecular Devices).
2.5. Fractionation of crude extracts – using column
chromatography
A column of 40 cm was filled up to 31 cm height having 2.5 cm
diameter with slurry of silica gel 60 (Merck) (0.063–0.2 mm
being the particle size 70–230 mesh). After equilibration of
the column with 100% methanol for 30 min, 5 g of the plant
extract along with 10 g gel was mixed in concentrated metha-
nol slurry. Air-dried mixture was then decanted to the top of
the packed column up to 7.5 cm in height. Firstly the column
was eluted by methanol at 40 drops per minute followed by
solvent combination of ethyl acetate/methanol/water (EMW)
in the ratio 20:2.7:2.5 (Masoko et al., 2008). Each fraction
was collected with a standard eluent volume of 200 mL. A
total of 15 fractions thus collected were subjected to a rotary
evaporator, concentrated until dryness and subsequently trans-
ferred to glass Petri dishes. Residual solvents were than gath-
ered after air-drying the dishes for 48 Hours. To determine
the number of phytocomponents in each fraction, primary
phytochemical methods were used (Harborne, 1984; Kim
et al., 2003).
2.6. Compound identification through gas chromatography &
mass spectrometry (GC/MS)
A Hewlett-Packard (HP) mass spectrometer interfaced with an
HP-6890 gas chromatograph with an HP5 column was used
for GC and GC/MS analysis. In split mode, sample was added
through the injector along with helium (carrier gas), with ini-
tial flow rate 0.7 ml/minute and a 32 cm/sec average linear
velocity. The settings of the temperature were as described here
in: injector temperature 220 C; oven temperature 70 C (ini-
tial), a 30 mL/min purge flow and 0.2 minute purge time,
5 C/minute ramp, final temperature 240 C, pressure of 8.20
psi. Mass spectra with pervious literature (Adams, 1995) wereused as identifier for compounds. Peak areas of the total frac-
tion composition were observed to record the percentage com-
position of every compound.
2.7. Anti-oxidant activity assay
Antioxidants react with 1, 1-diphenyl-2-picrylhydrazyl
(DPPH) stable free radicals to produce its reduced form
(DPPH-H). The DPPH-H formation in the reaction mixture
is assayed (Xiao et al., 2011) at A517. The reduction of the
DPPH radical to the DPPH-H form is indicated by the forma-
tion of a yellow color. A lower A517 of the reaction mixture
indicated a higher free radical scavenging activity. DPPH solu-
tion (0.1 mM) in methanol was prepared and 3.0 ml of purified
flavonoids at different concentrations was added to 1.0 ml of
this solution and 30 minutes later the A517 values were
recorded. A blank was prepared without adding flavonoids
to serve as a control. Ascorbic acid (1–18 lg/ml) was used as
a standard. The capability to scavenge the DPPH radicals
was determined as follows:
DPPH scavenged ð%Þ ¼ A517 control A517 test
A517 control
 1002.8. Determination of antibacterial activity by inhibitory
concentration (MIC50) of fractions
Micro-broth dilution method performed in 96-well plates to
determine the MIC50 of test fractions. Test fractions were
prepared at a concentration of 5.0 mg/mL, while gliricidin-
7-O-hexoside and quercetin 7-O-rutinoside were prepared at
a concentration of 2 lg/mL and 200 lg/mL respectively.
For nutrient broth two-fold dilutions of every fraction were
prepared in test wells. For such fractions, the ranges of the
final concentration were 2–2500 lg/ml, 0.001–2 lg/ml and
0.003–200 lg/ml, gliricidin-7-O-hexoside and quercetin-7-O-
rutinoside, respectively. Then, 20 lL of an 18-h-old broth cul-
ture of Gram-negative multidrug resistant suspension was
mixed with 100 lL of the fraction having the culture medium.
The preparation of control was done with the bacterial sus-
pension, culture medium and broth only. Alongside each
batch of tests at a concentration range of 0.0002–2 lg/mL,
positive-control antibiotic was amoxicillin. To check absor-
bance of plates after and before three days of incubation at
room temperature observed under micro-aerophilic situa-
tions, an automatic enzyme-linked immunosorbent assay
(ELISA) microplate reader adjusted to 610 nm was used.
To determine increase and decrease in bacterial growth,
absorbencies were compared and were represented graphi-
cally against concentration. Least concentration of fraction
resulting in inhibition of 50% bacterial growth was calculated
as MIC50.
2.9. Cytotoxicity assay
Uniform volumes of HepG2 and HeLa cell suspension (200 ll/
well; 2  104cell/ml) were poured into the selected wells of a
96-wells sterile tissue culture plate. The filter-sterilized fern
extract (200 lg/ml stock) was dispensed into the wells of the
microtiter plate to achieve final concentrations of 0–600 lg/
ml in Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma
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with gliricidin-7-O-hexoside and quercetin-7-O-rutinoside (the
flavonoids isolated in greatest quantities) were incubated in a
CO2 incubator with 95% humidity at 37 C for 16–18 h. The
DMEM (100 ll) was removed from each of the wells and
20 ll of freshly prepared MTT (5 mg/ml) was mixed in these
wells followed by incubation for 1 h at 37 C in a CO2 incuba-
tor. Thereafter, the DMEM containing MTT was completely
removed from the wells using a multi-channel auto-pipette
and the purple colored product by the cells in each of the wells
was extracted in DMSO (100 ll/well) and A570 values were
recorded in an ELISA reader. Each of the MFE concentra-
tions was tested in quadruplicate and mean values ± standard
deviation (SD) were calculated after the MTT assay. The
appropriate controls (containing an appropriate volume of
methanol alone) were also considered as a negative control
to determine the effect of methanol on the viability of the pro-
liferating cells cultured in vitro. Each analysis was performed in
triplicate and resulted as reproducible within experimental
errors (RSD < 5.0%), as was nearly comparable to standard
amoxicillin.2.10. Statistical analysis
Results values were taken as mean ± S.D. of three indepen-
dent and different experiments and were checked by a one-
way analysis of variance (ANOVA). Remarkable differences
were spotted at p< 0.05.
Gliricidin-7-O-hexoside, being the most abundant flavo-
noids (3.87%), followed by quercetin-7-O-rutinoside,
(3.09%), keampferol-3-O-rutinoside and myricetin-3-O-
rhamnoside were used against multidrug-resistant pathogens,
Proteus mirabilis, Proteus vulgaris and Pseudomonas
aeruginosa.3. Results
3.1. Chemical composition and percentage composition of
flavonoids in A.nidus
EAMW fractions 5 and 6 with the least number of components
were based on GC/MS analysis. 12 flavonoids were recognized
from present fractions, 3 were unknown flavonoids. EAMW
two of the fractions (fractions 1 and 3) revealed the presence
of compounds 3 and 12, respectively, representing 13.12%
and 2.61% and the total composition was 15.12%. The flavo-
noids detected were gliricidin-7-O-hexoside (3.87%) and
quercetin-7-O- rutinoside (3.09%) followed by keampferol-3-
O-rutinoside (0.9%) and myricetin-3-O-rhamnoside (1.10%).
Further information on the present phytochemical compound
composition is outlined in Table 1.3.2. Minimum inhibitory concentration (MIC50) of fractions
Out of 13 fractions collected, 12 showed remarkable anti-
bacterial activity. The MIC50 values of the fractions ran-
ged from 310 lg/ml to 2500 lg/ml; the ranges of amoxi-
cillin, gliricidin-7-O-hexoside and quercetin-7-O-rutinoside
were 0.0003–0.06 lg/ml, 0.004–0.06 lg/ml and 0.005–6.0 lg/mL, respectively, as shown in Table 2. Inhibition
values for gliricidin-7-O-hexoside and quercetin-7-O-
rutinoside were found to be comparable standard (amoxi-
cillin) (p> 0.05).
3.3. DPPH assay
The flavonoids from A. nidus exhibited notable DPPH radical
scavenging activity, which increased with increasing concentra-
tions. The scavenging activity of gliricidin-7-O-hexoside
(78.1%) was higher than that of quercetin-7-O-rutinoside
(69.2%) as presented in Fig. 2. The results indicate that the
maximum yield extracted flavonoids by A. nidus had a remark-
able DPPH radical-scavenging activity, underscoring the
potential clinical utility of these flavonoids.
3.4. Cytotoxicity assay
The observed results of MTT assay indicated that both potent
extracted flavonoids (gliricidin-7-O-hexoside and quercetin-7-
O-rutinoside) at all the selected concentrations (240 to
600 lg/ml) exhibited marked cytotoxicity or inhibitory effect
on the growth of HepG2 and HeLa cells (Table 3). The max-
imum viability of the mammalian cells was observed at
600 lg/ml of gliricidin-7-O-hexoside (HepaG2 76.15 ± 0.04)
and HeLa (66.91 ± 1.93). At enhanced concentration of
gliricidin-7-O-hexoside (600 lg/ml), a marked decline in the
viability of the cells was noticed indicating the inhibitory effect
of A.indus. These results indicate that flavonoids extracted by
A. indus had a remarkable cytotoxic activity, with an IC50
value of 507 lg/ml. Sylvestre et al. (2007) showed that the
bioactive compounds did not affect cell viability at concentra-
tions <100 lg/mL, thus validating its safety within this range.
It is interesting to note that in the current study, the compound
was active at concentrations <1 lg/mL. The high IC50 of the
two compounds indicate that they may be safe for human
consumption.4. Discussion
Continuous usage of available drugs in the market for the cure
of infections is severely hampered by the development of MDR
strains of pathogens; this fuels the likelihood of treatment fail-
ure, warranting the quest for novel and inevitable therapeutic
agents (Bohr and Malfertheiner, 2009). Study results
(Hammami et al., 2016; Bouhlali et al., 2016) have indicated
A. nidus (fern) as a promising, unexplored source of such
agents. Here we screened anti-bacterial, anti-oxidant and
anti-cancer inhibition activities against MDR pathogens of fla-
vonoids extracted from A. nidus.
Anti-bacterial activities were demonstrated by most of the
fractions as shown in Table 2, prime aim of fractionation
was to purify active phytochemicals (0.0003–0.06 lg/ml
0.004–0.06 lg/ml & 0.005–6.0 lg/ml, respectively. As expected
every fraction’s activity was similar to chemical composition of
its components, present ratios and their interactions with
examine bacteria, as referred to previously (Saidana et al.,
2008). Present data suggest that gliricidin-7-O-hexoside and
quercetin 7-O-rutinoside acted as major mediators for the
antimicrobial activity observed in A. nidus. The inhibitory
Table 1 Flavonoids isolated from the A.nidus as revealed by gas chromatography and mass spectrometry (GC/MS) analysis.a
Fraction Compound Chemical formula Rt (min) Area%
EAMW fraction 1 Globularin C24H28O11 4.24 1.03
Unknown – 4.83 0.3
Unknown – 5.46 0.2
Gliricidin 7-O-hexoside C21H20O11 7.93 3.83
Apigenin7-O-glucoside C21H20O10 10.01 1.6
Unknown – 16.20 0.4
Quercetin 7-O-rutinoside C27H30O16 21.80 3.09
Keampferol 7-O- C33H40O21 23.23 0.11
gentiobioside
Quercetin 7-O-galactoside C27H30O17 25.99 1.22
Myricetin 3-O-rhamnoside C21H20O12 28.57 1.10
Keampferol-3-O-rutinoside C27H30O15 32.76 0.19
Linoleic acid dimer C38H72N2O4 38.36 0.05
Total 13.12
Fraction 3 Keampferol 3-O-rhamnoside C21H19O10 40.40 1.01
Keampferol-7-O-rutinoside C27H30O15 43.34 0.7
Quercetin C21H20O11 51.12 0.9
Total 2.61
Rt, retention time; EMW, ethyl acetate/methanol/water.
a The alkane standard was C9–C28and the highest carbon number we had in our fraction was C20.
Table 2 50% Minimum inhibitory concentrations (MIC50) of
fractions, Gliricidin7-O-hexoside, quercetin 7-O-rutinoside,
and amoxicillin (lg/mL) against three multidrug resistant
pathogens.
MIC 50(lg/mL)
Proteus
mirabilis,
Proteus
vulgaris
Pseudomonas
aeruginosa
Fraction
EAMW1 310 630 1250
EAMW2 630 630 1250
EAMW3 630 310 630
EAMW4 630 310 310
EAMW5 630 310 310
EAMW6 310 630 630
EAMW7 630 630 630
EAMW8 630 –a –
EAMW9 630 310 630
EAMW10 310 310 630
EAMW11 630 310 1250
EAMW12 310 310 310
EAMW13 – – –
Compound
Gliricidin7-O-hexoside 0.04 0.0005 0.02
Quercetin 7-O-rutinoside 6.0 0.005 3.1
Amoxicillin 0.03 0.0003 0.03
EAMW-ethyl acetate/methanol/water.
a Indicates value not within susceptible range.
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cillin (p> 0.05), an antibiotic commonly used in the clinical
settings. This comparable inhibitory activity also enlightens
that present compound can be utilized as a possible substitute
in the formation of drug-resistant bacterial disease.The activity of gliricidin-7-O-hexoside activity was signifi-
cantly different from that of the EAMW fractions 4, 5, 1
and 12 (p< 0.05). Higher purification from these components
will therefore improve the activities of these fractions. In the
literature (Lai et al., 2009) also demonstrated anti-bacterial
activity against E. coli and P. aeruginosa. A similar finding
was reported for Dryopteris erythrosora (6.25 lg/ml) (Lee
et al., 2009) by the micro-dilution method.
The present study provided evidence for the anti-cancer
activity of gliricidin-7-O-hexoside on HepG2 and Hela cancer
cells as reflected by the values of 76.15 ± 0.04, 66.91 ± 1.93,
respectively, which were higher than the best value shown doc-
umented in previous studies. The EC50values of flavonoids on
HepG2 and Hela cancer cells have been reported to be 69.50
and 22.64 l M (43.21 and 12.31 lg/mL), respectively (Alia
et al., 2006) It is noteworthy that these flavonoids were active
at concentration levels less than 1 lg/ml, as outlined in Table 3.
The compounds did not affect cell viability at concentrations
<100 lg/mL, thus validating its safety within this range. It
is interesting to note that in the current study, the compound
was active at concentrations <1 lg/mL (Sylvestre et al.,
2007). The flavonol compounds display a remarkable spectrum
of biological activities including those that might be able to
influence processes that are dysregulated during cancer devel-
opment. These include, for example, antiallergic, anti-
inflammatory, antioxidant, antimutagenic, anticarcinogenic,
and modulation of enzymatic activities (Craig, 1999;
Middleton et al., 2000).
Both flavonoids with the greatest yield showed a significant
anti-oxidative activity in vitro: the DPPH radical scavenging
activity of gliricidin-7-O-hexoside (78.1%) was higher than
the quercetin-7-O-rutinoside (69.2%).The gliricidin-7-O-
hexoside has a higher number of hydroxyl groups that could
be responsible for the higher scavenging activity. Previous
reports have suggested that antioxidant activity of phenolics
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Figure 2 Anti-oxidant activity of flavonoids (gliricidin7-O-hexoside, and quercetin 7-O-rutinoside, from Asplenium nidus assessed by the
DPPH radical-scavenging assay. Data represent means ± SD of three independent experiments. j – Gliricidin-7-O-hexoside. N –
Quercetin-7-O-rutinoside.
Table 3 Cytotoxicity activity of Gliricidin7-O-hexoside and Quercetin 7-O-rutinoside against HepG2 and Hela cells.
Concentration (lg/mL) Cytotoxicity %
Gliricidin7-O-hexoside Quercetin 7-O-rutinoside
HepG2 HeLa HepG2 HeLa
0 100 100 100 100
240 30.64 ± 4.86 19.99 ± 3.33 30.64 ± 4.86 19.99 ± 3.33
360 5.67 ± 2.59 11.10 ± 2.10 5.67 ± 2.59 11.10 ± 2.10
480 36.53 ± 5.58 37.77 ± 5.34 5.67 ± 2.59 11.10 ± 2.10
600 76.15 ± 0.04 66.91 ± 1.93 5.67 ± 2.59 11.10 ± 2.10
190 R. Jarial et al.could be determined by the positions and number of hydroxyl
groups and that ortho-dihydroxy and glycosylation groups
were the most important structural features for their anti-
oxidant activity (Zhang et al., 2012). O-dihydroxy structure
in the B-ring (30 40-OH), the 2, 3-double bonds in combination
with a 4-oxo-group and the existence of both hydroxyl groups
in positions 3 and 5 determine the antioxidant activity of any
flavonoid. All these results illustrate the importance of the 3-
OH group in the C ring. The gliricidin-7-O-hexoside has the
highest and significant (p< 0.05) inhibitory potential than
the quercetin-7-O-rutinoside. Plant acts as electron donors
because of their content in phenolic compounds (Duthie and
Dobson, 1999). This may justify the DPPH radical scavenging
power noted in the tested falvonoids. This result corroborates
with previous study which demonstrated that DPPH scaveng-
ing properties of plant extracts increase with the concentration
of extracts (Gul et al., 2013; Kumar et al., 2014; Hilmi et al.,
2014). The inhibitory potential of the extracts tested rise with
the augmentation of concentration.
The percentage composition of gliricidin-7-O-hexoside
(3.83%) in the present fern (A. nidus) in the present study is
quite similar to the reports in Dryopteris erythrosora (2.1%)by Cao et al., 2013. At such high percentages this flavonoid
is isolated from A. nidus for the first time to our knowledge.
It is worth reporting that because of the meritorious anti-
bacterial, anti-oxidant and anti-cancerous activity demon-
strated by flavonoids (Mariya et al., 2015), they are being
researched with a view that people having asymptomatic gas-
tritis will be benefited from a nutritional approach. It may also
be useful in curing infection & thereby reduce the chances of
severe pathological conditions such as skin problems, wounds,
fever, cough and reproductive problems.
Another compound isolated in abundance in the current
study was quercetin-7-O-rutinoside (Table 1), which is used
in the pharmaceutical industry as a strong basic derivative,
especially as modifier anti-bacterial agents, (Cao et al.,
2013; Nicoletta et al., 2007). In this regard, however, toxico-
logical studies of flavonoids are warranted before therapeutic
application. Our research refers to be cautious about eth-
nomedicinal uses of A. nidus. We have used stem, leaves,
roots and barks of the present fern as remedies for many
serious diseases and these phytochemicals are safe, but since
their dosages are not standardized these may not be safe
every time.
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quercetinm-7-O-galactoside, kaempferol-7-O-gentiobioside,
kaempferol-3-O-rutinoside, myricetin-3-O in the A. nidus
(Table 1). However, flavonoid compositions are likely to be
dependent upon the nutritional status of the plant, geographic
location, soil composition, the parts of the plant subjected to
analysis, age and weather conditions (Ndhlala et al., 2007).
An important finding of the present study is that the pure fla-
vonoids found in the fern A. nidus are responsible for anti-
oxidant, anti-bacterial and anti-cancer activities.
These analyses suggest that A. nidus (fern) contains poten-
tially health-protective phytochemical compounds with a
potent source of natural anti-oxidants and anti-bacterial activ-
ities that may be clinically promising. Thus, it’s also adding
new compounds to the ever increasing canvas of phenolic com-
pounds acting as fountains of health.5. Conclusion
The fern A. nidus is a rich source of anti-bacterial, anti-
oxidant and anti-cancer phytochemical, with the major
flavonoid constituents being gliricidin-7-O-hexoside and
quercetin-7-O-rutinoside. Such potential properties of these
two bioactive compounds present considerable appeal to
utility in the pharmaceutical sector. The anti-bacterial activity
demonstrated by these isolated compounds can potentially
prove useful as novel agents against harmful pathogens and
may serve as a benchmark for the chemical synthesis of active
semi-synthetic analogs. Through further research on fern
toxicity, in vivo potential and implementation against MDR
pathogens will give better picture on their potent usage.
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